Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSomero Regulatory News (SOM)

Share Price Information for Somero (SOM)

Share Price is delayed by 15 minutes
Get Live Data
190.00    3.00 (1.62%)
Bid:
185.00
Ask:
195.00
Spread: 10.00 (5.405%)
Market Cap: £99.47m
SOM Live PriceLast checked at - London Stock Exchange

Intraday Somero Share Chart

Trading Statement

8 Feb 2010 07:00

RNS Number : 7908G
Somero Enterprises Inc.
08 February 2010
 

PRESS ANNOUNCEMENT

8 February 2010

 

 

Somero Enterprises, Inc ®

("Somero")

 

Trading update

 

The Board of Somero Enterprises, Inc, the North American manufacturer of patented laser guided equipment used for the spreading and levelling of high volumes of concrete for floors in the construction industry, provides the following update on trading for the year to 31 December 2009.

 

As we announced in November 2009, trading has remained difficult, and sales declined in the second half of 2009. However, full year results were broadly in line with our revised expectations and the business remained profitable.

 

We continue to manage our costs aggressively and, following the cost reduction programme in November, operating costs (excluding depreciation and amortisation) in 2010 are expected to be around $8.6 million, down from a level of $24 million in 2008.

 

Our lending bank remains supportive and we have re-set a 2009 year-end covenant and quarterly covenants in 2010 so that they are aligned with Somero's 2010 budget.

 

We believe that the outlook for 2010 is more positive than the previous year and we are expecting a gradual improvement starting in the second half of the year. As we have previously stated, we have not reduced headcount in the salesforce or the product development area, both of which are critical to support future sales, and Somero is currently introducing two new products at the World of Concrete trade show. We are also developing additional revenues in the faster growing economies such as China, Southeast Asia and parts of South America.

 

At the time of the placing announcement in June 2009, we stated the Board's intention to put in place a new employee share option scheme to retain and incentivise management. The Remuneration Committee has developed a substitute Stock Option scheme for management retention and incentivisation, which the Board intends to discuss with major shareholders in the near future.

 

Preliminary results for the year ended 31 December 2009 will be announced in May 2010.

 

Enquiries

 

 

 

Hawkpoint Partners Limited

+44 (0)20 7665 4500

Chris Robinson / Serge Rissi

 

 

 

Collins Stewart Europe Limited

+44 (0)20 7523 8000

Piers Coombs

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDELFBBLFZBBZ
Date   Source Headline
5th Jun 20267:00 amRNSAGM Statement
4th Jun 20267:47 amRNSTransaction in Own Shares and Total Voting Rights
2nd Jun 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
28th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
20th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
14th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
8th May 20262:53 pmRNSHolding(s) in Company
7th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Apr 20265:39 pmRNSUpdate regarding Company Shareholdings
30th Apr 20261:44 pmRNSTransaction in Own Shares and Total Voting Rights
30th Apr 20267:00 amRNSNotice of AGM & Director Succession Update
27th Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Apr 20267:00 amRNSHolding(s) in Company
21st Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Apr 20269:08 amRNSHolding(s) in Company
9th Apr 20267:00 amRNSBuyback Expansion and Further M&A Framework Detail
9th Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Mar 20265:27 pmRNSHolding(s) in Company
30th Mar 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Mar 20269:01 amRNSHolding(s) in Company
26th Mar 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Mar 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Mar 20267:00 amRNSHolding(s) in Company
24th Mar 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Mar 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Mar 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Mar 20267:00 amRNSLaunch of 2026 Share Buyback Programme
12th Mar 20267:00 amRNSLaunch of 2026 Share Buyback Programme
10th Mar 20267:00 amRNSFinal Results
17th Feb 20267:00 amRNSNotice of Investor Presentation
29th Jan 20267:00 amRNSTrading Update
20th Jan 20267:41 amRNSHolding(s) in Company
19th Dec 20252:28 pmRNSTransaction in Own Shares and Total Voting Rights
19th Dec 20252:28 pmRNSTransaction in Own Shares and Total Voting Rights
18th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Dec 20251:30 pmRNSTransaction in Own Shares and Total Voting Rights
5th Dec 20257:00 amRNSHolding(s) in Company
4th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Nov 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Nov 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Nov 20259:01 amRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.